Caribou Coffee Company Inc. (CBOU) operates coffeehouses primarily in the United States.  As of April 3, 2011, the Company had 544 coffeehouses, including 135 franchised locations, in 20 states, the District of Columbia and nine international markets. The Company provides the highest quality handcrafted beverages, foods and coffee lifestyle items with a unique blend of expertise, fun and authentic human connection in a comfortable and welcoming coffeehouse environment. In addition, CBOU’s unique coffees are available within grocery stores, mass merchandisers, club stores, office coffee and foodservice providers, hotels, entertainment venues and e-commerce channels.

Source: Reuters.com, SEC Filings.

Recent News

Shares of CBOU traded as much as 4% higher on Tuesday of last week on no news.  Trading volume that day jumped to more than 1.17 million shares from the previous day’s volume of about 679.10K.  Many investors seem to be bullish on the coffee and coffeehouse industry amid Dunkin’ Donuts‘ impending initial public offering, with major coffee plays recently outperforming the S&P 500.

CBOU has been moving within a range of $8.50 – $14.49 over the past 52 weeks. Shares pulled back on Friday, dropping as much as 5.4% to $13.  It is currently trading above its 50-day moving average of $11.61 and above its 200-day moving average of $10.23.

Financial Summary

CBOU posted net sales of $72.3 million for the first quarter of 2011, up 7.8% from $67.1 million posted in the comparable quarter of 2010. Coffeehouse sales were $57.6 million in the first quarter of 2011, an increase of 3.6% compared to $55.6 million in the first quarter of 2010. Commercial sales were $11.7 million in the first quarter of 2011, an increase of 29.7% compared to $9.0 million in the first quarter of 2010. Franchise sales were $3.0 million in the first quarter of 2011, an increase of 21.9% as compared with $2.5 million in the first quarter of 2010.

In the first quarter of 2011, the Company recorded a net income of $24.1 million, or $1.17 per diluted share, which includes a $21.3 million tax benefit related to the reversal of a tax valuation allowance. This compares to a net income of $1.0 million, or $0.05 per diluted share, in the same period last year.

Technical Analysis

Source: http://stockcharts.com

CBOU is within its Bollinger Bands. This is a normal condition suggesting that it is neither overbought nor oversold relative to the recent price action.

The MACD for CBOU currently indicates a strong bullish signal for two reasons. First, the MACD is above the signal line, a 9-day moving average. Second, the MACD is above 0, which implies that the underlying moving averages are trending higher.

Comparative Analysis

Source: Thomson Financial

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority.  We are neither licensed nor qualified to provide investment advice.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice.  The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities.  We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company.  An individual should never invest in the securities of any of the companies profiled based solely on information contained in our report.  Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.

Any individual who chooses to invest in any securities should do so with caution.  Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested.  Always research your own investments and consult with a registered investment advisor or licensed stock broker before investing.

Information contained in our report will contain “forward looking statements” as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934.  Subscribers are cautioned not to place undue reliance upon these forward looking statements.  These forward looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated.  Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company’s most recent reports or registration statements filed with the SEC.  You should consider these factors in evaluating the forward looking statements included in the report and not place undue reliance upon such statements.

We are committed to providing factual information on the companies that are profiled.  However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company’s plans or ability to effect any planned or proposed actions.  We have no first-hand knowledge of any profiled company’s operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so.  Statistical information, dollar amounts, and market size data was provided by the subject company and related sources which we believe to be reliable.

To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information).

We encourage you to invest carefully and read investment information available at the websites of the SEC at http://www.sec.gov and FINRA at http://www.finra.org.

Related Articles

1. Stock Alert for Coffee Holding Co. Inc. (JVA)
2. Javalution Coffee Company (JCOF)
3. Stock Alert for Javalution Coffee Co. (JCOF)

Coffee Holding Co. Inc. (JVA) operates as an integrated wholesale coffee roaster and dealer in the United States.  It offers a broad array of coffee products across the entire spectrum of consumer tastes, preferences and price points.  The Company’s private label and branded coffee products are sold throughout the United States, Canada and abroad to supermarkets, wholesalers, and individually owned and multi-unit retail customers.

Source: Reuters.com, SEC Filings.

Recent News

Shares of JVA soared to a new 52-week high of $26.82 on Friday.  The stock closed the session at $26.75, a gain of $4.40 on the day.  Over the last five sessions, the stock was up 75%. About 3.58 million shares have traded hands during the session, versus the 10-day average volume of 1.32 million. The stock is currently trading above its 50-day moving average of $11.96 and above its 200-day moving average $6.61. JVA’s recent jump, along with that of other coffee stocks, seemed to have been boosted by the impending IPO of Dunkin’ Donuts, which valuation has reportedly been increased.

JVA has a market cap of $146.86 million and shares outstanding of 5.49 million. The Company’s P/E ratio currently stands at 40, higher than the average food & beverage industry P/E ratio of 33.4 and the S&P 500 P/E ratio of 17.7.

Financial Summary

JVA posted net sales of $37.33 million for the three months ended April 30, 2011, up 87% from $19.92 million  reported in the comparable quarter last year. For the six months ended April 30, 2011, net sales totaled $62.97 million, up 52% $41.28 million reported for the six months ended April 30, 2010. The Company attributed the increase in net sales to higher sales prices, additional poundage sold due to the addition of its OPTCO subsidiary, as well as additional sales of green coffee to new customers.

For the three months ended April 30, 2011, the Company reported net income of $1.19 million, or $0.22 per share (basic and diluted), compared to net income of $800,448, or $0.15 per share (basic and diluted), for the three months ended April 30, 2010. Net income for the six months ended April 30, 2011, was $2.23 million, or $0.41 per share (basic and diluted), compared to $1.36 million, or $0.25 per share (basic and diluted), for the six months ended April 30, 2010. The increase in net income primarily reflects increased gross profit.

Technical Analysis

Source: http://stockcharts.com

JVA is above the upper Bollinger Band, implying that it is currently extended from its recent trend.

The MACD for JVA currently indicates a strong bullish signal for two reasons. First, the MACD is above the signal line, a 9-day moving average. Second, the MACD is above 0, which implies that the underlying moving averages are trending higher.

Comparative Analysis

Source: Thomson Financial

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority.  We are neither licensed nor qualified to provide investment advice.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice.  The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities.  We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company.  An individual should never invest in the securities of any of the companies profiled based solely on information contained in our report.  Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.

Any individual who chooses to invest in any securities should do so with caution.  Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested.  Always research your own investments and consult with a registered investment advisor or licensed stock broker before investing.

Information contained in our report will contain “forward looking statements” as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934.  Subscribers are cautioned not to place undue reliance upon these forward looking statements.  These forward looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated.  Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company’s most recent reports or registration statements filed with the SEC.  You should consider these factors in evaluating the forward looking statements included in the report and not place undue reliance upon such statements.

We are committed to providing factual information on the companies that are profiled.  However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company’s plans or ability to effect any planned or proposed actions.  We have no first-hand knowledge of any profiled company’s operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so.  Statistical information, dollar amounts, and market size data was provided by the subject company and related sources which we believe to be reliable.

To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information).

We encourage you to invest carefully and read investment information available at the websites of the SEC at http://www.sec.gov and FINRA at http://www.finra.org.

Related Articles

1. Stock Alert for Coffee Holding Co. Inc. (JVA)
2. Stock Alert for Caribou Coffee Company Inc. (CBOU)
3. Stock Alert for Jammin Java Corp. (JAMN)

Portage shares commenced trading on pinksheets this month, rallying from $0.15 on June 13 till the current quote of $0.95 on acquisition news.

Portage is focused on the exploration and production of precious and base metals in Peru, a country with a rich mining tradition and opportunities. Peru holds about 16% of the world’s known mineral reserves and is also known to have the largest silver reserves in the world. Many reserves have been exploited intensively in the past, however, to date only about 12% of Peru’s mineral resources have been worked. Accordingly, the country has the capacity to double the current levels of minerals output.

The Wukakuy Property, totaling 600 hectares, was acquired in exchange for 20 million shares of POTG from Airon Peru S.A.C. The project has estimated potential reserves in excess of 58 million oz of silver. Based on today’s silver prices of nearly $35/oz, the reserve estimates have a potential value in excess of $2 billion. Given these estimates, the project provides an immense opportunity for the company to start an extensive drill program and establish mining operations in Peru.

The second project, the Linderos #4 property was acquired in exchange of 10 million shares of Portage from Nilam Resources S.A. Based on data from Peruvian government, there are approximately 500,000  proven ounces of gold in the area of Linderos Project. Moreover, several independent studies evaluated that the project’s area could contain more than 1 million ounces of gold immediately near surface and the further drilling could significantly boost these estimates.

The escalating gold and silver prices have kept precious metals stock soaring during the course of 2010 and 2011.  The uncertain economic environment has spurted the investment demand for silver and gold, pushing prices to record levels in 2011. Silver reached an all time record of $49.51/oz on April 28, and is currently trading around $35/oz, compared to approximately $19/oz one year ago. A number of analysts expect silver prices to range above $50/oz in the next two-three years.

Gold prices have also ascended to record levels in 2011 hitting a record high of $1,575/oz last May. Since then, gold drifted back bellow $1,500/oz and is currently trading around $1,498/oz, compared to $1,244/oz one year ago. Analysts covering the market, expect the prices for gold to continue growing to reach $1,700 by the end of 2011.

As the economy recovers, silver companies could further benefit from the rebirth of silver industrial demand, thanks to the emergence and growth of a number of new end uses in computer and consumer electronics. According to the Silver Institute, the silver supply increased modestly by 2% per year over the last decade to approximate 710 million ounces in 2010. Meanwhile, the modest rise in supply is not sufficient to cover the burgeoning fabrication demand, which rebounded strongly in 2010 and is poised to outstrip supply in 2011.

The combination of strong investment and industrial demand could push silver prices to beat analyst’s estimations and set new records in the coming years. Portage is poised to benefit from strong industry’s fundamentals, despite the fact that it is in the early stage of exploration.

• This newsletter has been helping traders make a killing on POTG. Click here for a 25% discount offer.
• See today’s top stock picks and market analysis
• Need fast service and cheap rates from a broker? Buy stock online at my favorite brokerage
• Want more? Check out the message board buzz for POTG
• See which newsletters are recommending this stock pick
• Get breaking news alerts on this stock: http://www.thestockmarketwatch.com/

About Microstockprofit.com

Microstockprofit.com is committed to producing the highest-quality insight and analysis of small cap stocks, emerging technology stocks, hot penny stocks and helping investors make informed decisions. Our focus is primarily on the underserved OTC stocks market, or penny stock market, which has traditionally been shunned by Wall Street. We have particular expertise with renewable energy stocks, biotech stocks, oil stocks, green energy stocks and internet stocks. There are many hot penny stock opportunities present in the OTC market everyday and we seek to exploit these hot stock gains for our members before the average daytrader is aware of them.

Microstockprofit.com Disclaimer

This newsletter is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. Microstockprofit.com is a wholly owned subsidiary of BlueWave Advisors.

While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.

Related Articles

1. Portage Resources soars on Aggressive Acquisition Campaign
2. Pink Sheet Review; Portage Resources at a Glance
3. Stock Alert for Portage Resources Inc. (POTG)

Despite the growth, YRCW shares lost nearly 80% in 2011 due to challenging conditions in the trucking industry that made the company lose money in every quarter over the last three years. YRCW is currently struggling to avoid bankruptcy under a heavy debt load and tough competition. It negotiated with its lenders to soften the terms of its debt, asked workers to accept pay cuts, proposed debt-to-equity swaps and sold real estate to continue operations.

Moreover, the company’s plans to issue more shares and attract $100 million in capital, as well as a debt-to-equity conversion initiative, have also taken a tall on its valuation. These plans would dilute the interests of current shareholders to almost nothing. The dilution plans put the company in danger of delisting from Nasdaq, because its shares started to trade for less than the stock exchange’s minimum price of $1.

The trucking industry was beaten exceptionally hard during the economic crisis with nearly 2000 companies wiped out of business and others shrinking the size of their fleets. Only in 2010 demand begun to recover, giving truckers improved fundamentals. For 2010, the trucking tonnage was up 5.7% compared with 2009, according to American Trucking Associations (ATA).

During the first four months of 2011, the trucking tonnage continued the upward march with a year over year growth rate of 7.6% in January, 4.2% in February, 6.5% in March and 4.8% in April. Despite the fact that the growth slowed down in April, American Trucking Association representatives expressed anticipations that the freight volumes should increase for the remainder of 2011. Despite these anticipations, truck freight volume remains quite unpredictable.

The favorable industry conditions helped YRCW to stop the decline and report growth in Q1 2011. The company’s freight volumes grew year over year and consolidated operating revenue topped $1.12 billion, up 13% from $987.1 million a year earlier. The company has also reported that it lost $102 million, or $2.14 per share, in the quarter, a significant improvement from a year earlier when it lost $274 million, or $13.15 per share. Despite the improvements in cash flow generation, the huge debt levels, that exceed $1.06 billion, threatens severely the company’s ability to remain afloat.

Analysts surveyed by Thomson Reuters, had expected a loss of $(1.53) a share on $1.07 billion in revenue for Q1 2011.

According to management, operations have recovered significantly and with returning customers orders and confidence, YRCW is position to wipe out the bankruptcy threat in the quarters to come. In addition, the company reported that it has seen success in the second quarter of 2011, with national volumes per day up 7.6% and regional volumes per day up 8.5%. However, the current shareholders paid a huge price for this recovery, after handing over 97.5% of the ownership to YRCW’s lenders and labor union.

As the freight levels are expected to score significant growth in 2011, YRCW has the opportunity to capture the industry’s expansion and with a better cost structure to breakeven. However, the still fragile business as well as dilution to existing shareholders could negatively affect the company’s valuation.

• This newsletter has been helping traders make a killing on YRCW. Click here for a 25% discount offer.
• See today’s top stock picks and market analysis
• Need fast service and cheap rates from a broker? Buy stock online at my favorite brokerage
• Want more? Check out the message board buzz for YRCW
• See which newsletters are recommending this stock pick
• Get breaking news alerts on this stock: http://www.thestockmarketwatch.com/

About Microstockprofit.com

Microstockprofit.com is committed to producing the highest-quality insight and analysis of small cap stocks, emerging technology stocks, hot penny stocks and helping investors make informed decisions. Our focus is primarily on the underserved OTC stocks market, or penny stock market, which has traditionally been shunned by Wall Street. We have particular expertise with renewable energy stocks, biotech stocks, oil stocks, green energy stocks and internet stocks. There are many hot penny stock opportunities present in the OTC market everyday and we seek to exploit these hot stock gains for our members before the average daytrader is aware of them.

Microstockprofit.com Disclaimer

This newsletter is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. Microstockprofit.com is a wholly owned subsidiary of BlueWave Advisors.

While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.

Related Articles

1. Hot Stock Alert – YRC Worldwide bounces amid Tonnage Recovery and Default Fears
2. YRC Worldwide Shares surge on Positive Signs in Trucking Industry
3. OTCBB Stock Alert – YRC Worldwide Keeps Truckin’

REE boosted the indicated mineral resource estimate by approximately 20% to 4.9 million tons of 3.77% rare earth oxides. The company has also reported that the project’s resource estimates could be further upgraded, as the ongoing drilling program revealed additional mineralization targets.

According to management, the accumulated data on project justifies further technical work including drilling, metallurgical testing and engineering studies. As a result, REE plans to accelerate the exploration at Bear Lodge project and complete a preliminary feasibility study by the end of 2011. In addition, the company is looking to perform the first tests at a metallurgical plant this year on a sample of 10 tons of rare earth oxides.

The stock plunged 36% in 2011, after gaining more than 300% in 2010. The rally was supported by the stellar prices for REMs, however, the market pulled back on concerns that REE will need several years for exploration and production commencement.

REE is focused on exploring and developing economic mineral projects that contain or have the potential to contain rare-earth elements. The main focus of the company is advancing the Bear Lodge project located in Wyoming.  The Bear Lodge property is believed to contain one of the largest rare-earth deposits in North America, as well as extensive gold occurrences. The recent reports revealed that the project contains an inferred resource estimated of 17.8 million tons at 3.03% of rare-earth oxides. As of at December 31, 2010, REE had incurred a total of $9 million on exploration work at the Bear Lodge REE Project.

The company is aggressively exploring the project and plans to further expand the resource category as well as commence drilling in new prospective areas to better delineate the reserve volume. However, despite these achievements, REE is still several years from commencing production of rare earth minerals.

The growing demand for rare earth minerals, as well as an unstable supply has made REMs prices increase significantly over the last years. According to Metal Pages, the prices of rare earths have increased approximately 500% in 2010 from depressed prices in 2008. For example, according to Metal Pages, the prices of rare earth concentrates have increased from $4,500 per ton in July 2010 to approximately $38,000 per ton in December 2010.

REMs have significant importance to new technologies such as the iPhone and flat screen TVs, as well as to clean energy applications like electric car batteries, wind turbines and low energy bulbs. The surging demand for these products has made the demand for REMs to outpace supply and many analysts are now predicting approximately 40,000 tons annual shortfall by 2015. Accordingly, the development of domestic production of rare earth metals could make REE an important beneficiary of the REMs squeeze and positioned it for further appreciation.

Over 97% of rare earth metals are currently mined in China and the country’s government is trying to ensure that all raw REMs are processed within its borders and force major manufacturers of LCDs, mobile phones, computers, electric motors, etc. to relocate production in China.

During the past years, the Chinese government has reduced by 40% the amount of rare earths available for export. Even more, China has claimed in the beginning of 2011 once again its supremacy in the market by trimming the export quotas of REMs by 11.4% in the first round of permits for 2011 to 14,446 metric tons. The country cleared 16,304 and 7,976 tons of REMs for export in the two permit rounds in 2010. Accordingly, there are threatening opinions that China could halt REMs exports in 2012.

Going forward, REE is poised to benefit from strong fundamentals of the industry, particularly the solid and growing demand, record prices and a supply squeeze given the actions of the Chinese government to further diminish the REMs export quotas. Over the short term, REE valuation can get a boost from an upcoming announcement of the Chinese REMs export quotas for the second half of 2011.

• This newsletter has been helping traders make a killing on REE. Click here for a 25% discount offer.
• See today’s top stock picks and market analysis
• Need fast service and cheap rates from a broker? Buy stock online at my favorite brokerage
• Want more? Check out the message board buzz for REE
• See which newsletters are recommending this stock pick
• Get breaking news alerts on this stock: http://www.thestockmarketwatch.com/

About Microstockprofit.com

Microstockprofit.com is committed to producing the highest-quality insight and analysis of small cap stocks, emerging technology stocks, hot penny stocks and helping investors make informed decisions. Our focus is primarily on the underserved OTC stocks market, or penny stock market, which has traditionally been shunned by Wall Street. We have particular expertise with renewable energy stocks, biotech stocks, oil stocks, green energy stocks and internet stocks. There are many hot penny stock opportunities present in the OTC market everyday and we seek to exploit these hot stock gains for our members before the average daytrader is aware of them.

Microstockprofit.com Disclaimer

This newsletter is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. Microstockprofit.com is a wholly owned subsidiary of BlueWave Advisors.

While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.

Related Articles

1. Rare Earth Stock Review; Rare Element Resources on the Move
2. Stock Alert for Rare Element Resources Ltd. (REE)
3. Stock Alert for Rare Element Resources Ltd. (REE)

YRC Worldwide Inc. (YRCW), through its wholly owned operating subsidiaries, offers its customers a range of transportation services. These services include global, national and regional transportation, as well as logistics. Its operating subsidiaries include YRC National Transportation, which is a reporting unit for the transportation service providers focused on business opportunities in the regional national and international markets; YRC Regional Transportation is the reporting unit for the transportation service providers focused on business opportunities in the regional markets; YRC Logistics plans and coordinates the movement of goods worldwide to provide customers a single source for logistics management solutions, and YRC Truckload (Truckload) reflects the results of Glen Moore, a provider of truckload services throughout the United States.

The Company was incorporated in 1983 and is headquartered in Overland Park, Kansas.

Source: Reuters.com, SEC Filings.

Investment Highlights

Shares of YRCW hit a new 52-week low on Friday. The stock traded as low as $0.55 during the session before closing the day at $0.67, up almost 18% from the previous session. The stock saw trading at a volume of almost 4 million shares compared to the 10-day average of 47.77 million.  YRCW remains below its 50-day moving average of $1.19 and below its 200-day moving average of $2.57.  Market capitalization currently stands at $32.01 million and it has 47.77 million outstanding shares.

YRCW is the holding company for a portfolio of successful brands including YRC, YRC Reimer, YRC Glen Moore, Reddaway, Holland and New Penn, and provides China-based services through its Jiayu and JHJ joint ventures. The Company has the largest, most comprehensive less-than-truckload (LTL) network in North America with local, regional, national and international capabilities. Through its team of experienced service professionals, YRCW offers industry-leading expertise in heavyweight shipments and flexible supply chain solutions, ensuring customers can ship industrial, commercial and retail goods with confidence.

The trucking operator last month reported a net loss of $102 million and $(2.14) loss per share for the first quarter of 2011, narrowing the year-ago quarter loss of $274 million and $(13.15) loss per share.

YRCW reported first-quarter consolidated operating revenue of $1.1 billion and consolidated operating loss of $68 million, which were impacted by extreme winter weather and included $8 million of restructuring professional fee expenses. The Company also recorded a $17 million charge to increase its self-insured claims reserve, primarily related to workers’ compensation claims, which occurred during or were open and unsettled at the 2009 integration of the Yellow and Roadway network operations.

As a comparison, YRCW reported consolidated operating revenue of $987 million for the first quarter of 2010 and an operating loss of $233 million, which included a $108 million charge for union employee equity awards, $12 million of restructuring professional fee expenses and an $11 million charge for prior years’ self-insured claims.

Bill Trubeck, interim executive vice president, CFO and treasurer of YRCW, said that the Company’s first-quarter operating performance improved significantly once it moved past the severe winter weather in the first two months of the quarter.  Excluding insurance charge, the Company posted an adjusted EBITDA in excess of $20 million for the month of March.

At March 31, 2011, the Company reported cash and cash equivalents of $157 million, unrestricted availability of $8 million and unused restricted revolver reserves of $71 million, subject to the terms of the company’s credit agreement, as against cash and cash equivalents of $143 million, unrestricted availability of $51 million and unused restricted revolver reserves of $71 million, subject to the terms of the company’s credit agreement, at December 31, 2010.

YRCW is expected to report its next earnings on August 05, 2011. Trubeck stated, “With the operating momentum we achieved exiting the first quarter, which continued into April, we expect to achieve positive adjusted EBITDA in the second quarter of 2011.

Visit YRCW at www.yrcw.com

Technical Analysis

Source: http://stockcharts.com

YRCW is trading within its Bollinger Bands. This is a normal condition and suggests that the stock is neither overbought nor oversold relative to the recent price action.

YRCW’s MACD is currently indicating a weak bullish signal. Although the MACD is trending above the signal line, the indicator is still below 0, which suggests that the underlying moving averages are bearish.

Comparative Analysis

Source: Thomson Financial

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority.  We are neither licensed nor qualified to provide investment advice.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice.  The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities.  We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company.  An individual should never invest in the securities of any of the companies profiled based solely on information contained in our report.  Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.

Any individual who chooses to invest in any securities should do so with caution.  Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested.  Always research your own investments and consult with a registered investment advisor or licensed stock broker before investing.

Information contained in our report will contain “forward looking statements” as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934.  Subscribers are cautioned not to place undue reliance upon these forward looking statements.  These forward looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated.  Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company’s most recent reports or registration statements filed with the SEC.  You should consider these factors in evaluating the forward looking statements included in the report and not place undue reliance upon such statements.

We are committed to providing factual information on the companies that are profiled.  However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company’s plans or ability to effect any planned or proposed actions.  We have no first-hand knowledge of any profiled company’s operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so.  Statistical information, dollar amounts, and market size data was provided by the subject company and related sources which we believe to be reliable.

To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information).

We encourage you to invest carefully and read investment information available at the websites of the SEC at http://www.sec.gov and FINRA at http://www.finra.org.

Related Articles

1. Stock Alert for YRC Worldwide Inc. (YRCW)
2. YRC Worldwide Inc. (YRCW) Company Brief
3. Stock Alert for YRC Worldwide Inc. (YRCW)(D*)

The first version of the contract through BARDA was awarded last year to SIGA through a small business set-aside program. After complaints from rival Chimerix Inc., the U.S. Small Business Administration determined that SIGA did not qualify as a small business. BARDA’s new request for proposal, issued last February, omitted the rules about small business participation, making SIGA the only viable bidder.

Despite the recent win, the work on the contract was suspended again as Chimerix has filed a post-award protest against BARDA. Chimerix protested to the U.S. Government Accountability Office, contending procedures under which the contract was granted to SIGA. The protest is expected to be resolved in less than 100 days.

SIGA Technologies is applying viral and bacterial genomics and sophisticated computational modeling in the design and development of novel products for the prevention and treatment of serious infectious diseases, with an emphasis on products for biological warfare defense. The company has antiviral programs targeting smallpox and other Category A pathogens, including arenaviruses, dengue virus and the filoviruses (Ebola and Marburg).

The company’s leading compound, smallpox antiviral ST-246 (Tecovirimat), works by blocking the ability of the virus to spread to other cells, preventing disease symptoms in experimental models of smallpox without compromising acquisition of protective immunity.  Clinical studies support the use of ST-246 for treatment of smallpox and related human orthopoxvirus infections. The U.S. Food and drug administration (FDA) has designated ST-246 for “fast-track” status, creating a path for accelerated review and eventual regulatory approval.

The stock gained nearly 18% this year amid the recent contract win, protest from Chimerix, and disappointing results for Q4 2010 and Q1 2011.

Revenue for the three months ended March 31, 2011, was $1.7 million, compared to $5.1 million in the first quarter of 2010, and the operating loss for the quarter was $6.5 million, compared to $3.0 million for the comparable period last year. Net loss per share was $0.09 and $0.11 for the quarters ended March 31, 2011, and 2010, respectively. Cash and short-term investments on March 31, 2011, were $18.8 million, compared to $21.3 million on December 31, 2010.

In addition, the company reported that it has been recently awarded a $6.5 million grant from the National Institute of Allergy and Infectious Diseases. SIGA plans to use proceeds from the grant to fund continuing development of antiviral therapeutics for dengue virus.

The successful resolution of Chimerix complaints and execution of the contract with BARDA could generate significant revenue and earnings to SIGA and speed up the development of other treatment programs within its bio-defense segment. Analysts covering the company estimate that SIGA could supply 1.5 million doses per year, resulting in annual sales of $225 million. However, there are significant risks related to the lack of profitability, short operating history and the dependence on Government contracts to generate revenue.

• This newsletter has been helping traders make a killing on DRYS. Click here for a 25% discount offer.
• See today’s top stock picks and market analysis
• Need fast service and cheap rates from a broker? Buy stock online at my favorite brokerage
• Want more? Check out the message board buzz for DRYS
• See what newsletters are recommending this stock pick
• Get breaking news alerts on these stocks: http://thestockmarketwatch.com/

About Microstockprofit.com

Microstockprofit.com is committed to producing the highest-quality insight and analysis of small cap stocks, emerging technology stocks, hot penny stocks and helping investors make informed decisions. Our focus is primarily on the underserved OTC stocks market, or penny stock market, which has traditionally been shunned by Wall Street. We have particular expertise with renewable energy stocks, biotech stocks, oil stocks, green energy stocks and internet stocks. There are many hot penny stock opportunities present in the OTC market everyday and we seek to exploit these hot stock gains for our members before the average daytrader is aware of them.

Microstockprofit.com Disclaimer

This newsletter is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. Microstockprofit.com is a wholly owned subsidiary of BlueWave Advisors.

While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.

Related Articles

1. SIGA Technologies Soared 19% on expected Antiviral Contract
2. Powerwave Technologies reverses Trend on Strong Telecom Fundamentals
3. Hot Stock Alert – Netlist climbs on 3 Patents Award

Jammin Java provides premium roasted gourmet coffee on a wholesale level to the service, hospitality, office coffee service and big box store industry. The company owns “Marley Coffee” and related trademarks. Some of the key coffees that JAMN distributes are the Lion’s Blend (signature roast), Kingston City Roast (espresso) and The Mountain Roast (Swiss Water decaf). The company plans to capitalize on the success of the Marley name, as Rohan Marley, JAMN’s chairman, is the son of renowned reggae singer Bob Marley.

The coffee seller has recently made some changes to its management team, recruiting proven expertise in building sales and marketing awareness on online retailers and started to aggressively promote its offering. Subsequent to these changes, JAMN commenced selling its coffee on Cooking.com, MarleyCoffee.com and Amazon.com. The company has recently picked up the leading retailer Coffeewiz.com, a Web site dedicated to providing the best single serve coffees on the market, as another key online distributor.

The company has already reported solid customer response and accelerated revenue uptake from these channels as well as an optimistic outlook concerning its presence in the $4 billion U.S. single-serve coffee and tea pods market.

The company is following the success of Green Mountain Coffee Roasters Inc., (NASDAQ: GMCR), which expanded significantly over the last years to dominate the single-serve coffee market. Green Mountain’s coffee related revenues hit $1.2 billion in 2010 and, according to management’s outlook, are poised to soar between 82% and 87% in 2011. Green Mountain’s revenue for the second quarter of fiscal 2011 increased 101% to $647.7 million as compared to $322.0 million for the second quarter of fiscal 2010.

Last month JAMN launched a new line of products to tap the demand in the rapidly expanding single-serve coffee and tea pods markets. The company has also introduced the 2.5-ounce ground fractional packages of coffee, and 2.2-pound bags of whole beans.  With the introduction of tea in the company’s offering, JAMN plans to take advantage of the growing tea market with flavors such as Citrus White, Masala Chai and Rooibos Citron.

In addition, the coffee seller established several distribution agreements to cover the U.S. and Canada markets. JAMN has engaged National Coffee Service & Vending to oversee its national sales initiative for the U.S. office coffee services break room market and deploy its broker network to generate sales for the Jammin Java brands. The company has also appointed United Natural Foods Canada, a division of United National Foods Inc., as its Canadian distribution partner. Moreover, JAMN confirmed Gourmet Merchants International as their distributor in California.

The company has recently announced that it accessed a balance of the $2.5 million equity financing from undisclosed institutional investors to accelerate the product distribution.  The financing agreement, however, is extremely dilutive and grants investors the option to acquire JAMN’s share at a price of $0.40. To date JAMN has drawn 120,000 from the investors.

Despite the recent initiatives and solid customer response, there are still uncertainties regarding the marketing success of the company and the magnitude of growth. The delay in annual reports filing add further uncertainties. With a market capitalization of nearly $380 million, JAMN looks expensive for a company without revenue, lack of cash flows and elusive potential. The filing of financial reports for 2010 and Q1 2011 could help investors better understand the company’s potential.

• This newsletter has been helping traders make a killing on JAMN. Click here for a 25% discount offer.
• See today’s top stock picks and market analysis
• Need fast service and cheap rates from a broker? Buy stock online at my favorite brokerage
• Want more? Check out the message board buzz for JAMN
• See which newsletters are recommending this stock pick
• Get breaking news alerts on this stock: http://www.thestockmarketwatch.com/

About Microstockprofit.com

Microstockprofit.com is committed to producing the highest-quality insight and analysis of small cap stocks, emerging technology stocks, hot penny stocks and helping investors make informed decisions. Our focus is primarily on the underserved OTC stocks market, or penny stock market, which has traditionally been shunned by Wall Street. We have particular expertise with renewable energy stocks, biotech stocks, oil stocks, green energy stocks and internet stocks. There are many hot penny stock opportunities present in the OTC market everyday and we seek to exploit these hot stock gains for our members before the average daytrader is aware of them.

Microstockprofit.com Disclaimer

This newsletter is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. Microstockprofit.com is a wholly owned subsidiary of BlueWave Advisors.

While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.

Related Articles

1. Penny Stock in News: Jammin Java keeps it Hot
2. OTCBB Hot Stock; Jammin Java Delays filing its Annual Report
3. Jammin Java plunges on Profit-taking

Despite the recovery, ZAGG lost 20% this month due to Apple‘s (NASDAQ: AAPL) launch of the iPad Smart Cover, a slick, magnetic cover-cum-stand for the iPad and a direct competitor to ZAGG’s cases. While the introduction of the Smart Cover is not expected to be huge blow to ZAGG, since the company addresses a wider range of gadgets, the market realized the vulnerability of the company’s business to third-party developments and pressured down its valuation.

The subsequent release of Q4 2010 results, which topped the analyst estimates were not able to reverse the negative trend. Moreover, the market focused on worsening margins and outlook, which capped the company’s ability to grow exponentially in 2011.

ZAGG is a leader in providing clear and scratch-proof covers for smartphones, tablets and iPod touch media players. The company’s products are distributed worldwide with popular brands like the invisibleSHIELD, ZAGGskins, ZAGG LEATHERskins, etc. ZAGG’s flagship product, invisibleSHIELD, is the original thin film full-body protector, and is available in more than 5,000 precision pre-cut designs with a lifetime replacement warranty.

The company earned $10 million ($0.41 a share) on $76.1 million revenue in 2010, compared to $3.4 million ($0.15 a share) on $38.3 million revenue in 2009. Mobile (smartphone) sales account for 90% of its sales, while tablet products make near 7% of revenue mix.

During Q4 2010, ZAGG introduced the ZAGGmate, a protective and functional companion to the iPad that accentuates both the appearance and utility of APPL’s device. Made from aircraft-grade aluminum, ZAGGmate is a protective case, featuring a simple and innovative hinge stand for viewing and typing in portrait and landscape mode, with a version containing a built-in wireless Bluetooth keyboard. The keyboard availability significantly enhances the possibility to do real work on the tablet, since the touch keyboard is suitable for limited data entry and simple emails. The keyboard feature as well as the screen protection, positions ZAGGmate well to compete against AAPL’s iPad Smart Cover.

Benefiting from strong 2010 holiday season, as well as the introduction of new products, ZAGG reported a 157% growth in revenue to $29.3 million in Q4 2010 from Q4 2009 and a 27% sequential increase from Q3 2010. Gross margins slide to 46% in Q4 2010 from 54% in Q4 2009. The company earned $3.4 million or $0.13 a share in Q4 2010, compared to $0.3 million or $0.13 a share in Q4 2009. The average estimate polled by Thomson Reuters was for earnings of $0.12 a share on revenue of $21.2 million.

The company’s guidance for 2011 calls for revenue to climb 25% to 31% to $95-$100. Gross margins would further dip to 45% range, but operating margins should hold up well, due to the scale effect. Analysts, surveyed by Thompson Reuters, expect ZAGG to earn $0.50 a share on revenue of $100.2 million in 2011.

During 2010, ZAGG benefited from new distribution channels, the introduction of popular new devices such as the iPad and the iPhone 4 from Apple and other new mobile device introductions as well as continued strength in internet channels. ZAGG products are available online at ZAGG.com and in major retailers around the globe, including Best Buy, Target, RadioShack, Carphone Warehouse and hundreds of other retailers.

ZAGG shares are now trading at 14.89x this year projected profitability and 11.89x projected profitability for 2012. While the last month raised some doubts about the company’s ability to further gain market share, the current valuation looks cheap for a company poised to grow at double digits rates over the long term.

• This newsletter has been helping traders make a killing on ZAGG. Click here for a 25% discount offer.
• Need fast service and cheap rates from a broker? Buy stock online at my favorite brokerage
• Want more? Check out the message board buzz for ZAGG
• See what newsletters are recommending these stock picks
• Get breaking news alerts on these stocks: http://thestockmarketwatch.com/

About Microstockprofit.com

Microstockprofit.com is committed to producing the highest-quality insight and analysis of small cap stocks, emerging technology stocks, hot penny stocks and helping investors make informed decisions. Our focus is primarily on the underserved OTC stocks market, or penny stock market, which has traditionally been shunned by Wall Street. We have particular expertise with renewable energy stocks, biotech stocks, oil stocks, green energy stocks and internet stocks. There are many hot penny stock opportunities present in the OTC market everyday and we seek to exploit these hot stock gains for our members before the average daytrader is aware of them.

Microstockprofit.com Disclaimer

This newsletter is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. Microstockprofit.com is a wholly owned subsidiary of BlueWave Advisors.

Related Articles

1. Aoxing Pharma soars on Solid Volume and Short Squeeze Talks
2. ZAGG Soars on Robust Results and Bullish Outlook
3. Stock Alert for ZAGG Inc. (NASDAQ: ZAGG)

Cell Therapeutics shares sank 77% over the last year mainly due to the FDA refusal to approve pixantrone in March 2010, saying there was not enough evidence showing the drug is effective as a treatment for non-Hodgkin’s lymphoma. With a 52-week range of $0.12-$1.11, the March 9 trade was at $0.22, on the lower end of that range.

Cell Therapeutics is a biopharmaceutical company committed to developing an integrated portfolio of oncology products aimed at making cancer more treatable. The company’s leading drug candidate, pixantrone, is a novel anthracycline derivative for the treatment of non-Hodgkin’s lymphoma and various other hematologic malignancies and solid tumors. The phase III study results on drug achieved the primary efficacy endpoints, which made the company submit a New Drug Application with the FDA. However, the application was rejected, making CTIC to file an appeal last December and schedule additional clinical trials for 2011 and 2012.

Considering the previous records, the chances that the FDA would revisit the decision on pixantrone and approve the drug in the second quarter 2011 are slim. Therefore, additional clinical trials are inevitable.  The company has already announced a new clinical trial, referred to as the PIX-R or PIX 306 trial, to compare a combination of pixantrone plus rituximab to a combination of gemcitabine plus rituximab in patients with relapsed or refractory diffuse large B-cell lymphoma who have received one to three prior lines of therapy, utilizing progression free survival and Overall Survival as co-primary endpoints of the study. The trial is targeting to enroll approximately 350 patients over a period of 18 months.

As a result, the approval of pixantrone would most likely occur not earlier than in 2013. The delay would also result in additional research and development expenditures and dilution to existing shareholders. Cell Therapeutics had approximately $22.6 million in cash and cash equivalents as of December 31, 2010. Last February, the company upset its investors with additional dilution, reporting that it entered into a securities purchase agreement to sell up to $25 million worth of shares of its non-convertible preferred stock, warrants to acquire up to 25.9 million shares of common stock, and an additional investment right to acquire up to $25 million worth of shares of its convertible preferred stock.

Meanwhile, the company plans to promote pixantrone in Europe, where the Marketing Authorization Application for the drug as monotherapy for patients with relapsed or refractory aggressive non-Hodgkin’s lymphoma was validated and is currently under review by the European Medicines Agency based on the pixantrone phase III study results.

The company had no revenue in Q4 2010 and reported that it lost $34.1 million, compared to $27.4 million in the Q4 2009. Because of dilution, Cell Therapeutics’ per-share loss decreased to $0.4 from $0.5. The company had about 900 million shares outstanding as of February 14, up from 571 million a year ago.

Besides pixantrone, Cell Therapeutics’ other late-stage drug candidate Opaxio is being studied as a potential maintenance therapy for women with advanced stage ovarian cancer who achieve a complete remission following first-line therapy with paclitaxel and carboplatin. The phase III study on the drug is under the control of the Gynecologic Oncology Group, and is expected to enroll 1,100 patients with 765 patients enrolled as of December 31, 2010. Opaxio is also being studied in phase II trials for the treatment of metastatic esophageal cancer and brain cancer. These trials were completed in 2010 and demonstrated encouraging responses to therapy.

Cell Therapeutics is also developing brostallicin, which is a new class of cancer drug—a synthetic DNA minor groove binding agent with a unique mechanism of action. Brostallicin is currently in a phase II trial for the treatment of metastatic triple-negative breast cancer. This study is being conducted by the North Central Cancer Treatment Group and is in the process of enrolling patients.

The company’s current capitalization of nearly $200 million leaves significant room for growth and appreciation, given the market potential of pixantrone. According the Cell Therapeutics, the pixantrone revenue could reach $1 billion a year, in less than three years after the launch.

• Need fast service and cheap rates from a broker? Click here to see my favorite place to trade CTIC
• Want more? Check out the message board buzz for CTIC
• See what newsletters are recommending this stock pick
• Get breaking news alerts on this stock:  http://thestockmarketwatch.com/
• Want buy and sell signals? Premium newsletter, 15% off annual subscription – sign up today!

About Microstockprofit.com

Microstockprofit.com is committed to producing the highest-quality insight and analysis of small cap stocks, emerging technology stocks, hot penny stocks and helping investors make informed decisions. Our focus is primarily on the underserved OTC stocks market, or penny stock market, which has traditionally been shunned by Wall Street. We have particular expertise with renewable energy stocks, biotech stocks, oil stocks, green energy stocks and internet stocks. There are many hot penny stock opportunities present in the OTC market everyday and we seek to exploit these hot stock gains for our members before the average daytrader is aware of them.

Microstockprofit.com Disclaimer

This newsletter is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. Microstockprofit.com is a wholly owned subsidiary of BlueWave Advisors.

While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.

Related Articles

1. Cell Terapeutics Rallies on Pixantrone Resubmission Talks, Stock Position
2. Biotech Stock Talk; Cell Therapeutics Earnings Review
3. Stock Alert for Cell Therapeutics Inc. (CTIC)